ATE522214T1 - Therapeutisches mittel für nahrungskompetenzstörungen im magen - Google Patents
Therapeutisches mittel für nahrungskompetenzstörungen im magenInfo
- Publication number
- ATE522214T1 ATE522214T1 AT03745958T AT03745958T ATE522214T1 AT E522214 T1 ATE522214 T1 AT E522214T1 AT 03745958 T AT03745958 T AT 03745958T AT 03745958 T AT03745958 T AT 03745958T AT E522214 T1 ATE522214 T1 AT E522214T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- therapeutic agent
- competency
- nutritional
- stomach
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002104894 | 2002-04-08 | ||
PCT/JP2003/004445 WO2003084537A1 (fr) | 2002-04-08 | 2003-04-08 | Agent therapeutique traitant les troubles stomacaux de competence alimentaire |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE522214T1 true ATE522214T1 (de) | 2011-09-15 |
Family
ID=28786350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03745958T ATE522214T1 (de) | 2002-04-08 | 2003-04-08 | Therapeutisches mittel für nahrungskompetenzstörungen im magen |
Country Status (14)
Country | Link |
---|---|
US (4) | US20050176788A1 (fr) |
EP (2) | EP1493441B1 (fr) |
JP (2) | JP5281226B2 (fr) |
KR (4) | KR20050002925A (fr) |
CN (2) | CN102125551B (fr) |
AT (1) | ATE522214T1 (fr) |
AU (1) | AU2003236326B2 (fr) |
CA (1) | CA2481916C (fr) |
CY (1) | CY1112057T1 (fr) |
DK (1) | DK1493441T3 (fr) |
ES (1) | ES2368732T3 (fr) |
PT (1) | PT1493441E (fr) |
SI (1) | SI1493441T1 (fr) |
WO (1) | WO2003084537A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104447612A (zh) * | 2013-09-16 | 2015-03-25 | 天津市汉康医药生物技术有限公司 | 阿考替胺水合物晶型及其制备方法和用途 |
CN103980226A (zh) * | 2014-05-10 | 2014-08-13 | 杭州新博思生物医药有限公司 | 盐酸阿考替胺水合物晶型及其制备方法 |
CN105315225A (zh) * | 2014-07-07 | 2016-02-10 | 中美华世通生物医药科技(武汉)有限公司 | 阿考替胺的酸加成盐及其制备方法 |
CN104045606B (zh) * | 2014-07-11 | 2015-09-30 | 杭州新博思生物医药有限公司 | 一锅法制备阿考替胺盐酸盐的方法 |
CN109988121B (zh) * | 2019-04-28 | 2023-01-03 | 梯尔希(南京)药物研发有限公司 | 一种阿考替胺衍生物的制备方法 |
AR126442A1 (es) | 2021-07-14 | 2023-10-11 | Blueprint Medicines Corp | Inhibidores de map4k1 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1063442C (zh) | 1995-05-18 | 2001-03-21 | 泽里新药工业株式会社 | 氨基噻唑衍生物、含有它们的药物组合物及其用途 |
JPH10212271A (ja) * | 1997-01-31 | 1998-08-11 | Zeria Pharmaceut Co Ltd | N−置換ベンゾイルアミン誘導体、それを含有する医薬及び該化合物の製造中間体 |
US6197970B1 (en) * | 1997-06-24 | 2001-03-06 | Zeria Pharmaceutical Co., Ltd. | Process for producing 2-hydroxybenzamide derivatives |
US5981556A (en) * | 1997-07-22 | 1999-11-09 | G.D. Searle & Co. | 1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors |
KR20010080025A (ko) * | 1998-11-23 | 2001-08-22 | 디르크 반테 | 소화불량 치료용 의약의 제조를 위한 프루칼로프라이드의용도 |
JP2003501427A (ja) * | 1999-06-02 | 2003-01-14 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | アミノアルキル置換(ベンゾジオキサン、ベンゾフランもしくはベンゾピラン)誘導体 |
DE60025261T2 (de) * | 1999-11-23 | 2006-08-24 | Janssen Pharmaceutica N.V. | Verwendung von 5ht3 antagonisten zur fundusentspannung |
GB0002336D0 (en) * | 2000-02-01 | 2000-03-22 | Glaxo Group Ltd | Medicaments |
DK1315488T3 (da) * | 2000-09-08 | 2007-02-12 | Zeria Pharm Co Ltd | Farmaceutiske sammensætninger indeholdende aminothiazolderivater til behandling af motoriske funktionsforstyrrelser af tyktarm |
US6986882B2 (en) * | 2002-01-17 | 2006-01-17 | Astrazeneca Ab | Therapy for functional dyspepsia |
-
2003
- 2003-04-08 US US10/509,335 patent/US20050176788A1/en not_active Abandoned
- 2003-04-08 CN CN201010611741.5A patent/CN102125551B/zh not_active Expired - Lifetime
- 2003-04-08 AU AU2003236326A patent/AU2003236326B2/en not_active Expired
- 2003-04-08 AT AT03745958T patent/ATE522214T1/de active
- 2003-04-08 KR KR10-2004-7015764A patent/KR20050002925A/ko active Application Filing
- 2003-04-08 CN CNA038079755A patent/CN1646123A/zh active Pending
- 2003-04-08 KR KR1020117000220A patent/KR20110010837A/ko active Application Filing
- 2003-04-08 KR KR1020137022604A patent/KR101423284B1/ko active IP Right Review Request
- 2003-04-08 JP JP2003581777A patent/JP5281226B2/ja not_active Expired - Lifetime
- 2003-04-08 SI SI200332073T patent/SI1493441T1/sl unknown
- 2003-04-08 EP EP03745958A patent/EP1493441B1/fr not_active Expired - Lifetime
- 2003-04-08 ES ES03745958T patent/ES2368732T3/es not_active Expired - Lifetime
- 2003-04-08 PT PT03745958T patent/PT1493441E/pt unknown
- 2003-04-08 CA CA2481916A patent/CA2481916C/fr not_active Expired - Lifetime
- 2003-04-08 DK DK03745958.3T patent/DK1493441T3/da active
- 2003-04-08 KR KR1020127005319A patent/KR20120037035A/ko active Application Filing
- 2003-04-08 WO PCT/JP2003/004445 patent/WO2003084537A1/fr active Application Filing
- 2003-04-08 EP EP10010621A patent/EP2301540A1/fr not_active Withdrawn
-
2009
- 2009-02-17 US US12/372,234 patent/US20090156652A1/en not_active Abandoned
-
2011
- 2011-01-05 JP JP2011000499A patent/JP5360075B2/ja not_active Expired - Lifetime
- 2011-11-16 CY CY20111101103T patent/CY1112057T1/el unknown
-
2014
- 2014-12-22 US US14/579,102 patent/US20150141475A1/en not_active Abandoned
-
2020
- 2020-08-20 US US16/998,637 patent/US20200375954A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2003236326B2 (en) | 2008-02-28 |
KR20120037035A (ko) | 2012-04-18 |
JP5281226B2 (ja) | 2013-09-04 |
US20090156652A1 (en) | 2009-06-18 |
CY1112057T1 (el) | 2015-11-04 |
JP2011068692A (ja) | 2011-04-07 |
CN102125551A (zh) | 2011-07-20 |
US20150141475A1 (en) | 2015-05-21 |
KR20130101162A (ko) | 2013-09-12 |
EP2301540A1 (fr) | 2011-03-30 |
US20200375954A1 (en) | 2020-12-03 |
EP1493441A1 (fr) | 2005-01-05 |
CA2481916A1 (fr) | 2003-10-16 |
KR101423284B1 (ko) | 2014-07-24 |
EP1493441A4 (fr) | 2007-10-17 |
JP5360075B2 (ja) | 2013-12-04 |
JPWO2003084537A1 (ja) | 2005-08-11 |
US20050176788A1 (en) | 2005-08-11 |
ES2368732T3 (es) | 2011-11-21 |
AU2003236326A1 (en) | 2003-10-20 |
WO2003084537A1 (fr) | 2003-10-16 |
CA2481916C (fr) | 2013-02-26 |
SI1493441T1 (sl) | 2011-12-30 |
EP1493441B1 (fr) | 2011-08-31 |
PT1493441E (pt) | 2011-09-28 |
DK1493441T3 (da) | 2011-10-17 |
CN1646123A (zh) | 2005-07-27 |
KR20050002925A (ko) | 2005-01-10 |
CN102125551B (zh) | 2015-07-22 |
KR20110010837A (ko) | 2011-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1679309A4 (fr) | Medicament antistress et usage medical correspondant | |
DK1602660T3 (da) | Aminophosphonsyrederivater, additionssalte deraf og S1P-receptormodulatorer | |
NO20051209L (no) | Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk anvendelse derav samt intermediater for samme | |
DK1213296T3 (da) | Glucopyranosyloxpyrazolderivater, lægemidler indeholdende samme samt mellemprodukter til fremstilling heraf | |
DE602005023185D1 (de) | Prodrugs mit neuen biospaltbaren verbindern | |
BRPI0509258A (pt) | composto de 8-oxoadenina 9-substituìda | |
WO2008140099A1 (fr) | Dérivés de tétrazoyl-oxime et agent de lutte contre une maladie végétale | |
AU4396899A (en) | Remedies for diabetes | |
BR0307905A (pt) | derivados de benzotiofeno e benzofurano úteis no tratamento de distúrbios hiperproliferativos | |
SI1970372T1 (sl) | Soli 9-oksoakridin-10-ocetne kisline z 1-alkilamino-1-deoksi-polioli | |
WO2003059864A3 (fr) | Derives d'acide pheny(alkyl)carboxylique et derives phenylalkylheterocycliques dioniques et leur utilisation comme medicaments a activite d'abaissement de niveau de glucose serique et/ou lipides seriques | |
ATE522214T1 (de) | Therapeutisches mittel für nahrungskompetenzstörungen im magen | |
DE60325377D1 (de) | Motilidverbindungen | |
WO2006068306A3 (fr) | Composition de sterilisation contenant un acide o-alkoxyperoxy carboxylique | |
HK1129071A1 (en) | Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels | |
BRPI0511824A (pt) | radiossensibilizador | |
MY122570A (en) | Benzamide derivatives and drugs containing the same | |
HK1077070A1 (en) | Oligosaccharide derivative | |
BRPI0414580A (pt) | derivado do ácido fenilacético, processos para sua produção e uso | |
MXPA05008331A (es) | Derivados de 3-(benzoilureido)-tiofeno sustituido, metodo para su produccion y uso de los mismos. | |
MA27091A1 (fr) | Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
NO993911D0 (no) | Remedier/Forebygningsmidler for åndedrettssykdommer | |
EP1500656A4 (fr) | Derive de biguanides et agent de traitement du diabete en contenant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1493441 Country of ref document: EP |